Menu
09/05/2012
Arthritis Case's Predicted To Reach 17m By 2030
A new report has said that cases of osteoarthritis in Britain look set to double to over 17 million by 2030.
Published by the charity Arthritis Care the report says the predicted rise is down to the UK's ageing population and growing obesity problem.
Experts estimate that by 2030 over half of the UK population will be aged 50 or older and nearly the same proportion will be obese.
Its report - OANation 2012 - says 8.5 million people in the UK have osteoarthritis and 71% of them, some 6m people, are in constant pain.
Osteoarthritis (OA), the most common form of arthritis affects the joints, causing pain and stiffness and often reduced mobility. It usually develops in people aged over 50, but some are younger. The exact cause is not known, but anything that puts stress and strain on the joints - including obesity - can play a part.
Judith Brodie, CEO of Arthritis Care, said: "The individual, economic and societal burden of OA is already enormous, but with an ageing and increasingly obese population the future is looking bleak.
"We need policy-makers and professionals to take the condition seriously; to implement robust and meaningful strategies to address how OA is treated and managed across the UK and to improve health services."
Liam O'Toole of Arthritis Research UK welcomed the report, saying: "The increasing burden of osteoarthritis is exactly the reason we have continued to increase our research funding into this disease over the last few years."
(H)
Published by the charity Arthritis Care the report says the predicted rise is down to the UK's ageing population and growing obesity problem.
Experts estimate that by 2030 over half of the UK population will be aged 50 or older and nearly the same proportion will be obese.
Its report - OANation 2012 - says 8.5 million people in the UK have osteoarthritis and 71% of them, some 6m people, are in constant pain.
Osteoarthritis (OA), the most common form of arthritis affects the joints, causing pain and stiffness and often reduced mobility. It usually develops in people aged over 50, but some are younger. The exact cause is not known, but anything that puts stress and strain on the joints - including obesity - can play a part.
Judith Brodie, CEO of Arthritis Care, said: "The individual, economic and societal burden of OA is already enormous, but with an ageing and increasingly obese population the future is looking bleak.
"We need policy-makers and professionals to take the condition seriously; to implement robust and meaningful strategies to address how OA is treated and managed across the UK and to improve health services."
Liam O'Toole of Arthritis Research UK welcomed the report, saying: "The increasing burden of osteoarthritis is exactly the reason we have continued to increase our research funding into this disease over the last few years."
(H)
Related UK National News Stories
Click here for the latest headlines.
27 October 2008
Injection Offers New Hope For Arthritis Sufferers
A monthly injection could offer new hope to hundreds of thousands of arthritis sufferers, it has been revealed. An annual course of the antibody drug tocilizumab - which may be available on the NHS from as early as January - could stop the disease in its tracks, and could cost as little as £4,000.
Injection Offers New Hope For Arthritis Sufferers
A monthly injection could offer new hope to hundreds of thousands of arthritis sufferers, it has been revealed. An annual course of the antibody drug tocilizumab - which may be available on the NHS from as early as January - could stop the disease in its tracks, and could cost as little as £4,000.
22 August 2007
Arthritis Sufferers Win Right To Free Treatment
Many patients who suffer from severe arthritis have been given new hope after winning the right to free treatment with a "smart drug". The National Institute for Health and Clinical Excellence (NICE) has approved the drug MabThera for prescription in England and Wales.
Arthritis Sufferers Win Right To Free Treatment
Many patients who suffer from severe arthritis have been given new hope after winning the right to free treatment with a "smart drug". The National Institute for Health and Clinical Excellence (NICE) has approved the drug MabThera for prescription in England and Wales.
27 August 2013
MS And Parkinson's Sufferers Told They Are Fit To Work
Almost half of people with some progressive conditions, including Parkinson's, who put in a claim for the sickness benefit Employment and Support Allowance (ESA), are being told they will recover enough to look for work in the future.
MS And Parkinson's Sufferers Told They Are Fit To Work
Almost half of people with some progressive conditions, including Parkinson's, who put in a claim for the sickness benefit Employment and Support Allowance (ESA), are being told they will recover enough to look for work in the future.
15 December 2010
Smoking Behind Severe Arthritis Cases
Smoking accounts for more than a third of cases of the most severe and common form of rheumatoid arthritis, indicates new research. The research, published online in the Annals of the Rheumatic Diseases, says smoking accounts for more than half of cases in people who are genetically susceptible to development of the disease.
Smoking Behind Severe Arthritis Cases
Smoking accounts for more than a third of cases of the most severe and common form of rheumatoid arthritis, indicates new research. The research, published online in the Annals of the Rheumatic Diseases, says smoking accounts for more than half of cases in people who are genetically susceptible to development of the disease.
19 April 2006
Drug trial victims offered £5,000
Six volunteers who participated in a drug trial which left them seriously ill have been offered interim payments of £5,000 if they agree not to sue. Lawyers for four of the six men said that the manufacturer of the drug, TeGenero, had agreed to pay the men compensation on the condition that they accepted a “no-fault” procedure.
Drug trial victims offered £5,000
Six volunteers who participated in a drug trial which left them seriously ill have been offered interim payments of £5,000 if they agree not to sue. Lawyers for four of the six men said that the manufacturer of the drug, TeGenero, had agreed to pay the men compensation on the condition that they accepted a “no-fault” procedure.
-
Northern Ireland WeatherThis Evening and Tonight:A dry night, save for a few light showers around the coasts, with prolonged clear spells and light winds bringing a frosty dawn for many in central and southern parts. Minimum temperature -3 °C.
